NASDAQ:LOAN - Manhattan Bridge Capital Stock Price, Forecast & News

Manhattan Bridge Capital trades on the NASDAQ under the ticker symbol "LOAN."

Manhattan Bridge Capital declared a quarterly dividend on Wednesday, October 23rd. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.12 per share on Wednesday, January 15th. This represents a $0.48 annualized dividend and a dividend yield of 7.61%. The ex-dividend date is Monday, December 30th. View Manhattan Bridge Capital's Dividend History.

Manhattan Bridge Capital Inc. (NASDAQ:LOAN) released its quarterly earnings data on Monday, October, 21st. The credit services provider reported $0.12 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.11 by $0.01. The credit services provider earned $1.92 million during the quarter. Manhattan Bridge Capital had a return on equity of 13.50% and a net margin of 59.32%. View Manhattan Bridge Capital's Earnings History.

Manhattan Bridge Capital is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Manhattan Bridge Capital.

2 brokers have issued 1 year target prices for Manhattan Bridge Capital's stock. Their forecasts range from $8.00 to $8.00. On average, they expect Manhattan Bridge Capital's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 26.9% from the stock's current price. View Analyst Price Targets for Manhattan Bridge Capital.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Manhattan Bridge Capital in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Manhattan Bridge Capital.

Media stories about LOAN stock have trended positive this week, according to InfoTrie Sentiment. The research group ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Manhattan Bridge Capital earned a coverage optimism score of 2.5 on InfoTrie's scale. They also assigned news articles about the credit services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Manhattan Bridge Capital.

Manhattan Bridge Capital saw a decline in short interest in the month of December. As of December 31st, there was short interest totalling 1,700 shares, a decline of 48.5% from the December 15th total of 3,300 shares. Based on an average daily volume of 24,300 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are sold short. View Manhattan Bridge Capital's Current Options Chain.

Some companies that are related to Manhattan Bridge Capital include CIM Commercial Trust (CMCT), Farmland Partners (FPI), Clipper Realty (CLPR), CBL & Associates Properties (CBL), Maxus Realty Trust (MRTI), Ellington Residential Mortgage REIT (EARN), Sachem Capital (SACH), SOTHERLY HOTELS/SH SH (SOHO), Postal Realty Trust (PSTL), Hunt Companies Finance Trust (HCFT), Tremont Mortgage Trust (TRMT), AMEN Properties (AMEN), Global Self Storage (SELF), Spirit MTA REIT (SMTA) and Wheeler Real Estate Investment Trust (WHLR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Bridge Capital investors own include Allena Pharmaceuticals (ALNA), Energy Transfer LP Unit (ET), NovaBay Pharmaceuticals (NBY), AcelRx Pharmaceuticals (ACRX), Corbus Pharmaceuticals (CRBP), Rigel Pharmaceuticals (RIGL), Actinium Pharmaceuticals (ATNM), Arbutus Biopharma (ABUS), ArQule (ARQL) and Athersys (ATHX).

Manhattan Bridge Capital's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Centric Wealth Management (0.43%). Company insiders that own Manhattan Bridge Capital stock include Assaf Ran, Eran Goldshmit and Lyron L Bentovim. View Institutional Ownership Trends for Manhattan Bridge Capital.

LOAN stock was acquired by a variety of institutional investors in the last quarter, including Centric Wealth Management. View Insider Buying and Selling for Manhattan Bridge Capital.

Shares of LOAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LOAN stock can currently be purchased for approximately $6.30.

Manhattan Bridge Capital has a market capitalization of $60.90 million and generates $7.22 million in revenue each year. The credit services provider earns $4.20 million in net income (profit) each year or $0.48 on an earnings per share basis. Manhattan Bridge Capital employs 4 workers across the globe.View Additional Information About Manhattan Bridge Capital.

The official website for Manhattan Bridge Capital is http://www.manhattanbridgecapital.com/.

Manhattan Bridge Capital's mailing address is 60 CUTTER MILL RD. SUITE 205, GREAT NECK NY, 11021. The credit services provider can be reached via phone at 516-444-3400.